Renol Polychem IPO GMP: Day 1 IPO Live Updates

The Renol Polychem IPO GMP is ₹18 as of 31st July 2025. It is a bookbuilding IPO of ₹25.77 crores. This is an entirely fresh issue of 24.54 lakh shares. The issue will be listed on NSE and SME on its tentative listing date, 7th August 2025. The face value of Renol Polychem shares stands at ₹10 per share, and the IPO price band is set between ₹100 and ₹105 per share. Retail investors can bid for a minimum of 2 lots of 2,400 shares worth ₹2,52,000.

Renol Polychem IPO GMP Grey Market Premium

As of 31st July 2025, Renol Polychem IPO GMP stands at ₹18 per share. Thus, the estimated listing price would be ₹123. This indicates that the estimated listing gain in this IPO could be 17.14%. However, GMP details are subject to change based on market conditions and fluctuations. Explore the table for the Renol Polychem IPO GMP updates.

Renol Polychem IPO Details

Explanation

Renol Polychem IPO: Renol Polychem Limited has declared an issue price band of ₹100 to ₹105 per share. With this IPO, the company allows retail investors to bid for at least 2 lots of 2,000 shares worth ₹2,52,000. The face value of Renol Polychem Limited shares is ₹10 per share. The shares of Renol Polychem Limited will be listed on NSE and SME on its tentative listing day, 7th August 2025. Scroll down to check GMP updates and Renol Polychem IPO reviews. 

Objectives of Renol Polychem IPO

The primary aim of the Renol Polychem IPO is to raise ₹25.77 crores. On the other hand, Renol Polychem Limited has decided to utilise these funds in different prospects. Explore some of the secondary objectives for the Renol Polychem IPO.

• Capital expenditure is required for the purchase of machinery
• To fund the working capital requirement
• To meet the general corporate purpose.
• To repay a portion of certain borrowings availed by the company

Renol Polychem IPO Registrar

Skyline Financial Services Private Limited is the registrar of the Renol Polychem IPO, awaiting to manage the IPO allotment procedure and refund initiation. For any queries regarding the Renol Polychem allotment and refund, you can contact Skyline Financial Services Private Limited at info@skylinerta.com, 02228511022.

Renol Polychem IPO Review

The Renol Polychem IPO has gained neutral ratings from industry experts, brokers, and institutional investors. Renol Polychem Limited’s revenue soared by 859% from ₹6.52 crores in March 2024 to ₹62.56 crores in March 2025. Moreover, the company’s PAT increased by 226% from ₹1.53 crores to ₹5.00 crores. Investors can analyse other relevant factors and make a decision accordingly.

Most analysts recommend applying for this IPO to diversify your investment portfolio in the stock market. However, we’re waiting for further ratings to have a better idea and will keep posting them to deliver real-time insights. Until then, you can explore the company’s technical analysis to know whether you should apply for the Renol Polychem IPO or not.

Renol Polychem Limited Technicals

The PE ratio of Renol Polychem Limited shares is 11.54, and its Earnings Per Share (EPS) stands at 9.10. Thus, the Renol Polychem IPO can potentially deliver gains on its tentative listing date, 7th August 2025. 

Note: The data, as mentioned above, is taken from authentic sources and highlights pre-issue information. The PE ratio and EPS of Renol Polychem Limited are subject to change after the IPO. Explore the table below to get post-issue updates on these two metrics. 

Renol Polychem IPO Peer Comparison

For regular stock updates, dividend alerts, and expert verdicts, stay informed with Univest!

Also Read : Umiya Mobile IPO GMP: Day 1 IPO Live Update

FAQs on Renol Polychem IPO

What is the Renol Polychem IPO GMP?

Ans. Currently, on 31st July 2025, Renol Polychem  IPO GMP (Grey Market Premium) stands at ₹18. This indicates that the estimated listing price could be ₹123 per share.

What is the issue price of the Renol Polychem IPO?

Ans. Renol Polychem IPO price band has been set between ₹100 and ₹105 per share. Retail investors can apply for a minimum of 2 lots consisting of 2,400 shares worth ₹2,52,000. Moreover, HNIs are required to bid for a minimum of 3 lots (3,600 shares) worth ₹3,78,000. 

Who is the registrar of the Renol Polychem IPO?

Ans. Skyline Financial Services Private Limited is the registrar of the Renol Polychem IPO, awaiting to manage the IPO allotment procedure and refund initiation. For any queries regarding the Renol Polychem allotment and refund, you can contact Skyline Financial Services Private Limited at ipo@skylinerta.com or 02228511022.

Disclaimer: The above information is compiled from authentic sources and is just for informational purposes. To have detailed information about the Renol Polychem IPO, download the Renol Polychem IPO RHP and Renol Polychem IPO DRHP. Conduct your research before investing in IPOs to avoid significant losses. You can also consult your financial advisor.

Recent Article

Flysbs Aviation IPO GMP & Review: Apply or Avoid?

New India Assurance Company Q1 Results FY26: Q1 PAT Surged 67.29% to ₹400.33 Crore; Revenue Soared 10.26% YoY

Sri Lotus Developers IPO GMP: Day 1 IPO Live Updates

Varun Beverages Q1 Results FY26: Q1 PAT Surged 5.14% to ₹1,317.02 Crore; Revenue Dropped 2.33% YoY

Takyon Networks IPO GMP: Day 1 IPO Live Updates

Asian Paints Q1 Results FY26: Q1 PAT Plunged 6.00% to ₹1,099.77 Crore; Revenue Dropped 0.35% YoY